Whole grain diets lower risk of chron...(ronic diseases added Kris-Etherton. .....),Health
Home
Biology
Medicine
Technology
Products
News
Definition
Dictionary
Movies
Links
Tags
Search
RSS
Navigation Links
Biology News
Medicine News
Biology Products
Medicine Products
Biology Definition
Medicine Definition
Biology Technology
Medicine Technology
Biology Dictionary
Medicine Dictionary
HOME
>>
MEDICINE
>>
NEWS
Whole grain diets lower risk of chronic disease
ronic diseases added Kris-Etherton. ......
http://www.bio-medicine.org/inc/biomed/medicine-news.asp
http://feeds.bio-medicine.org/latest-medical-news
Date:2/5/2008
ronic diseases," added Kris-Etherton.
'/>"/>
Contact: Amitabh Avasthi
axa47@psu.edu
814-865-9481
Penn State
Source:
Eurekalert
0
GOOD
Page:
1
2
3
Related medicine news :
1
.
Colorado Residents and Visitors to Investigate Health in a Whole New Way
2
.
Hidden Veggies on the go hits Whole Foods Market(R) in 2008
3
.
Kim & Scotts Gourmet Pretzels(R) Introduces Its First Empowered Pretzel(TM) Available Online and to Wholesale
4
.
A Whole New Sandwich Debuts in the Freezer Aisle: LEAN POCKETS(R) Brand Introduces Latest Whole Grain Varieties
5
.
Fitness Sensation Susan Powter Returns to Her Legions of Fans and Followers with Focus on Whole Body Wellness Program
6
.
AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
7
.
Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case
8
.
Whole Grains Do a Heart Good
9
.
Whole Foods Market(R) Helps Shoppers Understand the Benefits of Natural Cosmetics
10
.
Whole Foods Market(R) Donates $25,000, for Midwest Farmers - Hoping to Match an Additional $10,000, via Customer Donations
11
.
Childs Flu Shot Helps Whole Family
Post Your Comments:
*
Name:
*
Comment:
*
Email:
Related Image:
Whole grain diets lower risk of chronic disease
Breaking Medicine News(10 mins):
Health News:MRI Partners with Natural Marketing Institute 2
Health News:MRI Partners with Natural Marketing Institute 3
Health News:MRI Partners with Natural Marketing Institute 4
Health News:Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar 2
Health News:Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar 3
Health News:FEHBP Open Enrollment Period to be Discussed on Special Rebroadcast of 'Inside Government' 2
Health News:Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health 2
[
1
] MRI Partners with Natural Marketing Institute
[
0
] University of Maryland chemist receives Astellas Award for blindness prevention research
[
0
] Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar
[
0
] FEHBP Open Enrollment Period to be Discussed on Special Rebroadcast of 'Inside Government'
[
0
] Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health
Other Medicine News:
Health News:eDiets.com(R) Announces Q3 2008 Results 2
Health News:eDiets.com(R) Announces Q3 2008 Results 3
Health News:eDiets.com(R) Announces Q3 2008 Results 4
Health News:eDiets.com(R) Announces Q3 2008 Results 5
Health News:eDiets.com(R) Announces Q3 2008 Results 6
Health News:eDiets.com(R) Announces Q3 2008 Results 7
Health News:Pelvic Inflammation Puts Girls at Risk for Repeat STIs 2
Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 2
Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 3
Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 4
Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 2
Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 3
Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 4
Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 5
Health News:Leading Scientists From Around the World Headed to Kansas for Symposium on Combating Deadly Infectious Diseases 2
Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 2
Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 3
Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 4
eDiets.com(R) Announces Q3 2008 Results
Pelvic Inflammation Puts Girls at Risk for Repeat STIs
Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
Top NY Court Blinks in 'First Department' WPP Discrimination Power Play
Leading Scientists From Around the World Headed to Kansas for Symposium on Combating Deadly Infectious Diseases
FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause
Breaking Medicine Technology:
Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2
New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2
New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3
New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4
China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2
China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3
China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4
China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5
China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6
China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7
China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8
Preventing toxic shock syndrome and other severe diseases 53247 1
Got zinc 3F New zinc research suggests novel therapeutic targets 9433 1
Got zinc 3F New zinc research suggests novel therapeutic targets 9433 2
Recovery act funded research projects aid communities across the country 9428 1
[
0
] Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline
[
0
] New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals
[
0
] China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009
Other Medicine Technology:
Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer 2
Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer 3
Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer 4
Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia 2
Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia 3
Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer
Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia
Medicine Products:
STA REPTILASE
FIBRI-PREST AUTOMATE 2
STA NEOPLASTINE CI + 5 (ISI ~ 1.3)
Calcium CPC AMP (DIMENSION)
Biology Navigation
AIDS/HIV
Bioinformatics
Biotechnology
Biochemistry
Cancer
Cell Biology
Developmental Biology
Ecology
Environment
Evolution
Food Technology
Gene
Genetics
Genomics
Health/Medicine
Immunology
Microarray
Microbiology
Molecular
Marine Biology
Nanobiotechnology
Neurobiology
Plant Sciences
Stem Cell
Systems Biology
Virus
Women Health
Medical Navigation
Abortion
Aches
ADHD
Addiction
Alcohol
Allergy
Alternative Medicine
Alzheimer's Dementia
Anxiety/Stress
Arthritis
Autism
Bacteria
Blood
Bird Flu/Avian Flu
Bones
Breast Cancer
Cancer
Cardiovascular
Cervical Cancer
Chikungunya
Cholesterol
Clinical Trials
Colorectal Cancer
Conferences
Crohn's
Cystic Fibrosis
Dengue
Dentistry
Depression
Diabetes
Drug
Eating Disorders
Education
Epilepsy
Erectile Dysfunction
Eye Health/Blindness
Fertility
Flu/Cold
GastroIntestinal
Genetics
Gout
Headache/Migraine
Hearing/Deafness
HIV/AIDS
Huntington's Disease
Hypertension
Immune System/Vaccines
Insurance
Infectious Diseases
Irritable-Bowel Syndrome
Internet
Leukemia
Lifestyle
Liver Disease/Hepatitis
Lung Cancer
Lupus
Mad Cow Disease
Medical Devices
Medical Students/Training
Medicare/Medicaid
Medico
Men's health
Mental Health
MRI/Ultrasound
MRSA/Drug Resistance
Multiple Sclerosis
Muscular Dystrophy
Neurology
Nursing
Nutrition/Diet
Obesity/Weight Loss
Pain/Anesthetics
Parkinson's Disease
Pediatrics/Children's Health
Pharma/Biotech Industry
Pharmacy/Pharmacists
Pregnancy
Premature
Prostate
Psychology/Psychiatry
Rehabilitation
Respiratory/Asthma
SARS
Schizophrenia
Seniors/Aging
Sexual Health
Sleep/Sleep Disorders
Smoking
Statins
Stem Cell Research
Stroke
Surgery
Transplants/Organ Donations
Viruses
Water - Air Quality
Women's Health